8,084views
Biochemistry
Glycolysis
Citric acid cycle
Electron transport chain and oxidative phosphorylation
Gluconeogenesis
Glycogen metabolism
Pentose phosphate pathway
Physiological changes during exercise
Amino acid metabolism
Nitrogen and urea cycle
Fatty acid synthesis
Fatty acid oxidation
Ketone body metabolism
Cholesterol metabolism
Essential fructosuria
Hereditary fructose intolerance
Galactosemia
Pyruvate dehydrogenase deficiency
Glucose-6-phosphate dehydrogenase (G6PD) deficiency
Lactose intolerance
Glycogen storage disease type I
Glycogen storage disease type II (NORD)
Glycogen storage disease type III
Glycogen storage disease type IV
Glycogen storage disease type V
Leukodystrophy
Metachromatic leukodystrophy (NORD)
Krabbe disease
Gaucher disease (NORD)
Niemann-Pick disease types A and B (NORD)
Niemann-Pick disease type C
Fabry disease (NORD)
Tay-Sachs disease (NORD)
Mucopolysaccharide storage disease type 1 (Hurler syndrome) (NORD)
Mucopolysaccharide storage disease type 2 (Hunter syndrome) (NORD)
Cystinosis
Hartnup disease
Alkaptonuria
Ornithine transcarbamylase deficiency
Phenylketonuria (NORD)
Cystinuria (NORD)
Homocystinuria
Maple syrup urine disease
Abetalipoproteinemia
Familial hypercholesterolemia
Hypertriglyceridemia
Hyperlipidemia
Disorders of carbohydrate metabolism: Pathology review
Disorders of fatty acid metabolism: Pathology review
Dyslipidemias: Pathology review
Glycogen storage disorders: Pathology review
Lysosomal storage disorders: Pathology review
Disorders of amino acid metabolism: Pathology review
Hyperlipidemia
0 / 20 complete
0 / 5 complete
of complete
of complete
2022
2021
2020
2019
2018
2017
2016
glycoprotein IIb/IIa inhibitors for p. 445
glycoprotein IIb/IIa inhibitors p. 445
hyperlipidemia p. 307
atherosclerosis and p. 308
atypical antipsychotics p. 597
glomerular filtration barrier and p. 605
immunosuppressants p. 118
nephrotic syndrome p. 619
thiazides p. 633
hyperlipidemia signs p. 307
glycoprotein IIb/IIa inhibitors as cause p. 445
hyperlipidemia and p. 307
Hyperlipidemia is a condition where you have high levels of lipids in your blood, specifically above 200 mg/dL of triglycerides and above 190 mg/dL of cholesterol. Among the causes of hyperlipidemia are genetic predisposition, high-fat diet, and sedentary lifestyle. There are also secondary causes like diabetes mellitus, metabolic disorders such as hypothyroidism. Hyperlipidemia can lead to cardiovascular and cerebrovascular diseases such as myocardial infarction and stroke.
Copyright © 2023 Elsevier, except certain content provided by third parties
Cookies are used by this site.
USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.